Calibration and validation of a microporous polyethylene passive sampler for quantitative estimation of illicit drug and pharmaceutical and personal care product (PPCP) concentrations in wastewater influent

Abstract

Wastewater-based epidemiology (WBE), the per capita normalised measurement of drugs, chemicals or metabolites in wastewater influent, relies on sampling and quantitative analysis to evaluate temporal and spatial trends of chemical consumption. Continuous, high-resolution, flow proportional composite sampling is optimal for accurate representations of chemical mass loads, but is rarely implemented, with conventional autosamplers providing relatively low frequency time or volume proportional samples. However, due to equipment or resource constraints at many wastewater treatment plants (WWTPs), even this may not be feasible. Passive sampling may provide an alternative sampling strategy. To investigate this, samplers comprising hollow, cylindrical Microporous Polyethylene Tubes (MPTs) containing polymeric sorbent phases of Strata-X and Strata-X in agarose were simultaneously deployed in a municipal WWTP influent stream. Samplers were extracted, analysed and evaluated for a range of illicit drugs and pharmaceuticals and personal care products (PPCPs) after 4, 7, 15, 21, and 29 day deployments. The MPT samplers were calibrated against 24-hour time proportional composite grab samples that were collected in parallel. Diffusion through the MPT governed uptake, reducing or eliminating the influence of external flow rates that may fluctuate unpredictably in a WWTP environment. Calibration data for six illicit drugs and fourteen PPCPs, including methamphetamine, benzoylecgonine, MDMA, codeine and carbamazepine, demonstrated linear accumulation in the samplers (R2 ≥ 0.84). Derived sampling rates for these analytes ranged from 0.25 to 17 mL d−1 for ibuprofen and verapamil, respectively. A validation study using this sampling rate data showed the MPT could effectively quantify concentrations (≥0.1 ng mL−1) of a range of amphetamine-type stimulants, opioids and metabolites as well as nicotine, accounting for 95% of the variance in parallel composite grab sample concentrations of these compounds. The MPT sampler shows promise for providing essential monitoring data for WBE, informing future intervention and research strategies.